By Ivan Diaz-Padilla, Senior Vice President and Global Head, Oncology Therapeutic Area Unit, R&D Acute myeloid leukaemia (AML) remains a
Category: Science
Choosing the hardest problems: why Ipsen focuses where unmet need is greatest
By Christelle Huguet, EVP & Head of R&D, Ipsen In biopharmaceutical research, not all challenges are equal. Some of the most
Why post approval evidence is redefining the future of patient care
By Sandra Silvestri, for Ipsen.com In today’s rapidly evolving treatment landscape the approval of a medicine is no longer the
A moment worth remembering: what SCALE tells us about the future of aesthetics
Olivia Brown, EVP, Head of Neuroscience There are moments that stay with you. Not because of a single slide or
Right medicine, right person: Jacintha Sivarajah on science with purpose
“All medicines have side effects, but it’s just about trying to minimize the impact through providing the information patients and clinicians need or finding other
Strategic Focus: Alexis Cocozaki on the pathway to early discovery at Ipsen
“To succeed at this, you need to have some tolerance for failure and risk taking.” At the heart of Ipsen’s
A Life in Science: The role of data in advancing medicines
New in our A Life in Science series, we hear from Audrey Clapéron, Translational Biology Director, about the essential role of data in
From culture to clinic: Alison Mason on making science work at scale
“We’re doing real science. For real people. And we’re doing it together. That’s what matters most to me.” – Alison Mason The science
A Life in Science: Shaping early development with patient focus
New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development,
A Life in Science: Curiosity and collaboration in cancer research
New in our A Life in Science series, we hear from Elodie Lewkowicz, Asset Lead, about how curiosity and collaboration